Product NDC: | 68516-3602 |
Proprietary Name: | AlphaNine |
Non Proprietary Name: | COAGULATION FACTOR IX (HUMAN) |
Active Ingredient(s): | & nbsp; COAGULATION FACTOR IX (HUMAN) |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | KIT |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68516-3602 |
Labeler Name: | Grifols Biologicals Inc. |
Product Type: | PLASMA DERIVATIVE |
FDA Application Number: | BLA103249 |
Marketing Category: | BLA |
Start Marketing Date: | 19901231 |
Package NDC: | 68516-3602-2 |
Package Description: | 1 KIT in 1 CARTON (68516-3602-2) * 10 mL in 1 VIAL (68516-3605-2) * 10 mL in 1 VIAL, SINGLE-DOSE (63323-185-10) |
NDC Code | 68516-3602-2 |
Proprietary Name | AlphaNine |
Package Description | 1 KIT in 1 CARTON (68516-3602-2) * 10 mL in 1 VIAL (68516-3605-2) * 10 mL in 1 VIAL, SINGLE-DOSE (63323-185-10) |
Product NDC | 68516-3602 |
Product Type Name | PLASMA DERIVATIVE |
Non Proprietary Name | COAGULATION FACTOR IX (HUMAN) |
Dosage Form Name | KIT |
Route Name | INTRAVENOUS |
Start Marketing Date | 19901231 |
Marketing Category Name | BLA |
Labeler Name | Grifols Biologicals Inc. |
Substance Name | |
Strength Number | |
Strength Unit | |
Pharmaceutical Classes |